valproic acid and p276-00

valproic acid has been researched along with p276-00 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chaudhari, U; Joshi, K; Rathos, M; Shirsath, N; Sivaramakrishnan, H	1

Other Studies

1 other study(ies) available for valproic acid and p276-00

Article	Year
Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines. Lung cancer (Amsterdam, Netherlands), 2013, Volume: 82, Issue:2 Topics: Acetylation; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinases; Flavones; Histone Deacetylase Inhibitors; Histones; Humans; Lung Neoplasms; Mice; Protein Kinase Inhibitors; Tumor Stem Cell Assay; Valproic Acid; Xenograft Model Antitumor Assays	2013

Article

Year

Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.

Lung cancer (Amsterdam, Netherlands), 2013, Volume: 82, Issue:2

Topics: Acetylation; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinases; Flavones; Histone Deacetylase Inhibitors; Histones; Humans; Lung Neoplasms; Mice; Protein Kinase Inhibitors; Tumor Stem Cell Assay; Valproic Acid; Xenograft Model Antitumor Assays

2013